Skip to main content
Premium Trial:

Request an Annual Quote

Fanelli Appointed VP Sales For Base4 Bioinformatics

Premium

MISSISSAUGA, Ont.--Base4 Bioinformatics announced that Joe Fanelli joined the pharmaceutical informatics company as vice-president of sales and marketing. Fanelli, who was most recently vice-president for Quantum Biotechnologies, will be stationed at Base4's US headquarters in San Diego, Calif. Fanelli has also held senior management positions in early-stage and major biomedical firms including Roche Diagnostics, Beckman, Cetus, Microgenics, and Cangene.

Martin Sumner Smith, Base4's president, said that, now that the company has invested heavily in product development, Fanelli will build the sales and marketing infrastructure to propel Base4 into the "prominent supplier position for the bioinformatics market." Base4's Pharmatrix software product provides collaborative knowledge and project management capabilities to pharmaceutical research organizations. The company also develops custom databases for unique applications in pharmaceutical and biotechnology companies.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.